| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $6.4M | +30.3% |
| SG&A Expense | $8.8M | +7.8% |
| Operating Income | -$23.5M | -14.3% |
| Interest Expense | $218K | — |
| Pre-tax Income | -$23.7M | -15.2% |
| Income Tax | $1.1M | +83.5% |
| Net Income | -$24.8M | -17.1% |
| EPS (Basic) | -$0.34 | -9.7% |
| EPS (Diluted) | -$0.34 |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Inventory | $22.3M | +169.5% |
| Current Assets | $27.5M | +151.1% |
| Total Assets | $100.9M | +19.6% |
| Current Liabilities | $49.5M | +51.3% |
| Total Liabilities | $56.1M | +46.7% |
| Stockholders' Equity | $44.9M | -2.8% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.5M | -4446.6% |
| Investing Cash Flow | -$5.8M | -15.0% |
| Financing Cash Flow | $15.2M | +211.2% |
| -9.7% |